Page results
-
This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery.
-
This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery for patients (or their family or carers) who have been referred to our service or are under the care of the team at this hospital.
-
Fibreoptic Endoscopic Evaluation of Swallow (FEES) patient information leaflet
-
The iconic run has returned to its regular time of the year, following two years’ disruption following the pandemic and will take place on Sunday 2 October 2022. We are lucky enough to have five people running for UCLH Charity. The money they raise will help us support patients, staff and research at UCLH.
-
The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.
-
This page provides information on examinations using contrast agents in MRI. It is intended for use by patients (or their families or carers) who have been referred to our service for imaging requiring contrast agents.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
Information on contrast agents for X-ray, fluoroscopy, CT and angiography examinations at NHNN
-
Advice on preventing the spread of flu and other respiratory viruses, to keep UCLH patients safe.
-
This page tells you about the procedure known as varicocele (pronounced VARI-CO-SEAL) embolisation.
File results
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer
-
FOI/2022/0194 - Drug treatment for lung cancer